Zengeza Clinical Research Site
Welcome,         Profile    Billing    Logout  
 3 Trials 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mgodi, Nyaradzo
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD Development, LP
HIV Infections
06/28
06/28
NCT05458765: Project Engage: Oral PrEP Acceptability

Completed
2
330
RoW
emtricitabine/tenofovir alafenamide, Descovy, Emtricitabine / Tenofovir Disoproxil Oral Tablet, Truvada
Eastern Virginia Medical School, CONRAD, FHI 360, United States Agency for International Development (USAID), Gilead Sciences
Acceptability of Health Care, Adherence, Medication
12/23
07/24
Musara, Petina
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mgodi, Nyaradzo
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD Development, LP
HIV Infections
06/28
06/28
NCT05458765: Project Engage: Oral PrEP Acceptability

Completed
2
330
RoW
emtricitabine/tenofovir alafenamide, Descovy, Emtricitabine / Tenofovir Disoproxil Oral Tablet, Truvada
Eastern Virginia Medical School, CONRAD, FHI 360, United States Agency for International Development (USAID), Gilead Sciences
Acceptability of Health Care, Adherence, Medication
12/23
07/24
Musara, Petina
No trials found

Download Options